NEPH
$3.00
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological ...
Recent News
Nephros Inc (NEPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures
Nephros Inc (NEPH) reports a 33% annual revenue increase, while navigating tariff impacts and expanding into non-medical markets.
Nephros (NEPH) Q4 2025 Earnings Call Transcript
Robert Banks: Thank you, Kirin. Clean water is essential for health care, hospitality, food services and everyday life. Together, these pillars are driving our growth and positioning Nephros as a leader in water safety solutions.
Nephros, Inc. Q4 2025 Earnings Call Summary
Moby summary of Nephros, Inc.'s Q4 2025 earnings call
Promising Penny Stocks To Consider In February 2026
As February begins, U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. While larger market trends capture headlines, investors often overlook smaller opportunities such as penny stocks, which despite their vintage name, continue to offer potential for significant returns when backed by solid financials. This article explores three promising penny stocks that combine balance sheet strength with...
Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks
As February begins, the U.S. stock market is showing strength, with major indexes like the Dow Jones and S&P 500 posting significant gains. In this context of rising indices, investors often look for opportunities that may offer growth potential at a lower entry cost. Penny stocks, though considered a niche investment area today, still hold promise by offering access to smaller or newer companies that can potentially deliver strong returns when backed by solid financials. Let's explore...